Novartis | Cafepharma Message Boards | Pharma Sales, Device …
Apr 17, 2025 · Anonymous board for Novartis.
October 27 2025 - Novartis shares slip, Avidity soars after $12 …
4 days ago · Novartis shares slip, Avidity soars after $12 billion biotech dealNovartis boardInnovent, Lilly's mazdutide trumps Novo's semaglutide in head-to-head diabetes, weight …
Novartis | Cafepharma
4 days ago · Novartis has shared detailed data showing its radioligand therapy Pluvicto could slow the progression of certain hormone-sensitive prostate cancers ahead of a planned application …
Novartis | Cafepharma
Novartis, Bristol Myers Squibb and Johnson & Johnson racked up court losses this month in cases challenging the legality of drug price negotiations created under the Inflation Reduction …
Cafepharma - Home | pharma sales, device sales, lab sales
3 days ago · Regeneron board Novartis Q3 operating income up 6% on new drug sales Novartis board Multiple sclerosis: three trials to watch Novartis board Merck-Eisai's kidney cancer drug …
Xolair | Cafepharma
Mar 4, 2025 · Xolair, a 20-year-old asthma drug sold by Roche (ROG.S) and Novartis (NOVN.S) significantly reduced allergic reactions in people with multiple severe food allergies in a late …
Medical Equipment/Device Sales - Cafepharma
Anonymous discussion boards for medical equipment/device companies
Novartis ‘moving as fast as possible’ to fully manufacture key …
Jul 17, 2025 · In its Q2 earnings call Thursday, Novartis said it is moving quickly to reshore its drug manufacturing operations, but CEO Vas Narasimhan told reporters that for most …
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Anonymous discussion boards for pharmaceutical sales, medical/device sales, lab/diagnostics sales
Xoma | Cafepharma
Sep 23, 2025 · Novartis is discontinuing the development of the anti-TGFβ antibody NIS793 and is returning it to Xoma Corporation, according to an SEC filing posted Friday. Following the …